Business · 19/01/1996Updated: 10/18/2026 · 1 min read
FDA Announces Public Workshop on Creutzfeldt-Jakob Disease Transmission via Plasma and Plasma Derivatives
Summary
The FDA is hosting a public workshop to discuss experimental study designs for investigating the possible transmission of Creutzfeldt-Jakob Disease by plasma and plasma-derived products, with the goal of advancing laboratory methods for this research.